|
|
 Previous Article | Table of Contents | Next Article 
Association of Specific Cytomegalovirus Genotypes With Death From Myelosuppression After Marrow Transplantation
Beverly Torok-Storb,
Michael Boeckh,
Cynthia Hoy,
Wendy Leisenring,
David Myerson, and
Ted Gooley
From the Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA.
A retrospective analysis of cytomegalovirus (CMV) genotype was conducted on 281 CMV isolates obtained from marrow transplant recipients. The genotyping was based on sequence variations in the gene encoding envelope glycoprotein B (gB) as detected by restriction analysis of polymerase chain reaction (PCR)-amplified gB DNA. Among all isolates studied, the distribution of gB types 1-4 was 48.4%, 16.4%, 24.6%, and 8.2%, respectively, with only 2.5% of all isolates containing more than one gB type. The association of gB types with acute graft-versus-host-disease (GVHD) and death related to myelosuppression was examined using appropriate multivariable regression models. Covariables in addition to gB type included underlying disease type, donor-recipient HLA matching, donor CMV serostatus, and age as a continuous variable. Death associated with myelosuppression occurred in 2.9% or 4 of 136 patients with gB1, 0% or 0 of 46 patients with gB2, 21.7% or 15 of 69 patients with gB3, and 17.4% or four of 23 patients with gB4. The significant association of CMV gB type with death due to myelosuppression was maintained in a multivariable analysis (P < .001). In addition, the data also suggested that gB types 3 and 4 may be associated with a reduced hazard of grades II to IV acute GVHD.
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 2097-2102
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X. Pang, A. Humar, and J. K. Preiksaitis
Concurrent Genotyping and Quantitation of Cytomegalovirus gB Genotypes in Solid-Organ-Transplant Recipients by Use of a Real-Time PCR Assay
J. Clin. Microbiol.,
December 1, 2008;
46(12):
4004 - 4010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gealy, M. Denson, C. Humphreys, B. McSharry, G. Wilkinson, and R. Caswell
Posttranscriptional Suppression of Interleukin-6 Production by Human Cytomegalovirus
J. Virol.,
January 1, 2005;
79(1):
472 - 485.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Goodrum, C. T. Jordan, S. S. Terhune, K. High, and T. Shenk
Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations
Blood,
August 1, 2004;
104(3):
687 - 695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Wang, C. La Rosa, R. Maas, H. Ly, J. Brewer, S. Mekhoubad, P. Daftarian, J. Longmate, W. J. Britt, and D. J. Diamond
Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus
J. Virol.,
April 15, 2004;
78(8):
3965 - 3976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Murphy, D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk
Coding potential of laboratory and clinical strains of human cytomegalovirus
PNAS,
December 9, 2003;
100(25):
14976 - 14981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tarrago, C. Quereda, and A. Tenorio
Different Cytomegalovirus Glycoprotein B Genotype Distribution in Serum and Cerebrospinal Fluid Specimens Determined by a Novel Multiplex Nested PCR
J. Clin. Microbiol.,
July 1, 2003;
41(7):
2872 - 2877.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. D. Goodrum, C. T. Jordan, K. High, and T. Shenk
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency
PNAS,
December 10, 2002;
99(25):
16255 - 16260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Rasmussen, A. Geissler, C. Cowan, A. Chase, and M. Winters
The Genes Encoding the gCIII Complex of Human Cytomegalovirus Exist in Highly Diverse Combinations in Clinical Isolates
J. Virol.,
October 2, 2002;
76(21):
10841 - 10848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Torok-Storb, L. Bolles, M. Iwata, K. Doney, G. E. Sale, T. A. Gooley, and R. Storb
Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia
Blood,
August 1, 2001;
98(3):
891 - 892.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. S. Lurain, K. S. Kapell, D. D. Huang, J. A. Short, J. Paintsil, E. Winkfield, C. A. Benedict, C. F. Ware, and J. W. Bremer
Human Cytomegalovirus UL144 Open Reading Frame: Sequence Hypervariability in Low-Passage Clinical Isolates
J. Virol.,
December 1, 1999;
73(12):
10040 - 10050.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. P. Alderete, S. Jarrahian, and A. P. Geballe
Translational Effects of Mutations and Polymorphisms in a Repressive Upstream Open Reading Frame of the Human Cytomegalovirus UL4 Gene
J. Virol.,
October 1, 1999;
73(10):
8330 - 8337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Iwata, J. Vieira, M. Byrne, H. Horton, and B. Torok-Storb
Interleukin-1 (IL-1) Inhibits Growth of Cytomegalovirus in Human Marrow Stromal Cells: Inhibition Is Reversed Upon Removal of IL-1
Blood,
July 15, 1999;
94(2):
572 - 578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
